\u30db\u30fc\u30e0<\/a>\u3000\uff1e\u3000 \u7814\u7a76\u7d39\u4ecb<\/a>\u3000\uff1e\u3000 \u696d\u7e3e<\/a>\u3000\uff1e\u3000\u8457\u66f8\u30fb\u8ad6\u6587\uff082004\uff09<\/div>\n

\u8457\u66f8\u30fb\u8ad6\u6587\uff082004\uff09<\/div>\n

Thesis 2004<\/b><\/span><\/p>\n<\/div>\n

\n
$\"\"$ <\/a><\/div>\n
$\"\u898b\u5b66\u306e\u3054\u6848\u5185\"$ <\/a><\/div>\n<\/div>\n
<\/p>\n<\/div>\n
<\/p>\n
<\/div>\n
<\/div>\n
\u5e73\u621016\uff082004\uff09\u5e74\u767a\u8868\u306e\u8ad6\u6587\u3068\u8457\u66f8\u3067\u3059\u3002<\/p>\n

\n \u4ee4\u548c\u5143\uff082019\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621030\uff082018\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621029\uff082017\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621028\uff082016\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621027\uff082015\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621026\uff082014\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621025\uff082013\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621024\uff082012\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621023\uff082011\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621022\uff082010\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621021\uff082009\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621020\uff082008\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621019\uff082007\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621018\uff082006\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621017\uff082005\uff09\u5e74<\/a>\u3000|\u3000 \u5e73\u621016\uff082004\uff09\u5e74<\/a>
\n<\/span><\/p>\n
\n
\u56fd\u969b\u8a8c<\/span><\/div>\n
<\/div>\n
Wada JA, Hirayasu Y. Lasting secondary antiepileptogenesis induced by cingulate kindling. Epilepsia. 45(11):1308-16, 2004.<\/p>\n
Namihira T, Hirayasu Y, Koga Y. The assessment of cognitive function in a Williams syndrome patient: a case report. Psychiatry Clin Neurosci. 58(1):99, 2004<\/p>\n
Yamasue H, Iwanami A, Hirayasu Y, Yamada H, Abe O, Kuroki N, Fukuda R, Tsujii K, Aoki S, Ohtomo K, Kato N, Kasai K. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res. 15;131(3):195-207, 2004.<\/p>\n
Wiegand LC, Warfield SK, Levitt JJ, Hirayasu Y, Salisbury DF, Heckers S, Dickey CC, Kikinis R, Jolesz FA, McCarley RW, Shenton ME. Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study. Biol Psychiatry. 15;55(2):131-40, 2004<\/p>\n
Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Lee CU, McCarley RW, Shenton ME. ollow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophr Res. 1;71(2-3):349-351, 2004.<\/p>\n
Odawara T, Iseki E, Kanai A, Arai T, Katsuragi T, Furukawa Y, Hino H, Yamamoto T, Kosaka K: Clinicopathological study of two subtypes of Pick\u2019s disease in Japan.Review series dementia,2:9-11,2004<\/p>\n
Kawanishi C, Lundgren S, Agren H, Bertilsson L: Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study. Eur J Clin Pharmacol, 59, 804-807, 2004<\/p>\n
Onishi H, Kawanishi C, Onose M, Yamada T, Saito H, Yoshida A, Noda K: Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: report of 3 cases and review of the literature. Supprort Care Cancer, 12, 604-608, 2004<\/p>\n
Matsumoto T, Azekawa T, Yamaguchi A, Asami T, Iseki E: Habitual self-mutilation in Japan. Psychiatry and clinical neurosciences 58: 191-198, 2004<\/p>\n
Matsumoto T, Yamaguchi A, Chiba Y, Asami T, Iseki E, Hirayasu Y. Patterns of self-cutting: a preliminary study on differences in clinical implications between wrist- and arm-cutting using a Japanese juvenile detention center sample. Psychiatry Clin Neurosci. 58(4):377-82, 2004.<\/p>\n
Matsumoto T, Kawanishi C, Isojima D, Iseki E, Kishida I, Kosaka K: Neuroleptic malignant syndrome induced by donepezil. Int J Neuropsychopharm, 7, 101-103, 2004<\/p>\n
Togo T, Katsuse O, Iseki E. Nitric oxide pathways in Alzheimer’s disease and other neurodegenerative dementias. Neurol Res. 26(5):563-6, 2004.<\/p>\n
Togo T, Kojima K, Shoji M, Kase A, Uchikado H, Katsuse O, Iseki E, Kosaka K. Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study. Int Clin Psychopharmacol. 19(1):37-40, 2004.<\/p>\n
Togo T, Akiyama H, Iseki E, Uchikado H, Kondo H, Ikeda K, Tsuchiya K, de Silva R, Lees A, Kosaka K. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. Acta Neuropathol (Berl). 107(6):504-8, 2004.<\/p>\n
Togo T, Hasegawa K, Miura S, Hosojima H, Kojima K, Shoji M, Kase A, Uchikado H, Iseki E, Kosaka K. Serum ghrelin concentrations in patients receiving olanzapine or risperidone.<\/p>\n
Psychopharmacology (Berl). 172(2):230-2, 2004.<\/p>\n
Furukawa R, Iseki E, Hino H, Kanai A, Odawara T, Kosaka K: Ubiquitin and ubiquitin-related proteins in neurons and dendrites of brains of atypical Pick\u2019s disease without Pick bodies. Neuropathology,24:38-45,2004<\/p>\n
Furukawa R, Iseki E, Hino H, Odawara T, Ikeda K, Tsuchiya K, Kosaka K: Ubiquitin and ubiquitin-related proteins in the brains of patients with atypical Pick\u2019s disease without Pick bodies and dementia with motor neuron disease. Neuropathology, 24: 306-314,2004<\/p>\n
Uchikado H, Akiyama H, Kondo H, Ikeda K, Tsuchiya K, Kato M, Oda T, Togo T, Iseki E, Kosaka K. Activation of vascular endothelial cells and perivascular cells by systemic inflammation-an immunohistochemical study of postmortem human brain tissues. Acta Neuropathol (Berl). 107(4):341-51, 2004.<\/p>\n
Katsuse O, Dickson DW. Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy. Acta Neuropathol 108: 143-146, 2004.<\/p>\n
Kishida I, Kawanishi C, Furuno T, Kato D, Ishigami T, Kosaka K: Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 receptor gene. Mol Psychiatry, 9, 293-298, 2004<\/p>\n
Narita H, Odawara T, Iseki E, Kosaka K, Hirayasu Y. Psychomotor retardation correlates with frontal hypoperfusion and the Modified Stroop Test in patients under 60-years-old with major depression. Psychiatry Clin Neurosci. 58(4):389-95, 2004.<\/p>\n
<\/div>\n
\u56fd\u5185\u8a8c<\/span><\/div>\n
<\/div>\n
\u7dcf\u8aac\u3092\u542b\u3080<\/div>\n
\u5e73\u5b89\u826f\u96c4: \u5dfb\u982d\u8a00\uff1a\u795e\u5948\u5ddd\u770c\u7cbe\u795e\u533b\u5b66\u4f1a\u306e\u5c55\u671b\u3000\u795e\u5948\u5ddd\u7cbe\u795e\u533b\u5b66\u4f1a\u8a8c, 53, 1, 2003\uff082004\u5e74\u767a\u884c\uff09<\/p>\n
\u5e73\u5b89\u826f\u96c4: \u6297\u7cbe\u795e\u75c5\u85ac\u591a\u5264\u4f75\u7528\u30fb\u5927\u91cf\u6295\u4e0e\u304b\u3089\u6e1b\u91cf\u30fb\u5358\u5264\u5316\u3078\u306e\u5207\u308a\u66ff\u3048\u65b9\u6cd5. \u81e8\u5e8a\u7cbe\u795e\u85ac\u7406, 7, 59-63, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4: \u7cbe\u795e\u795e\u7d4c\u75be\u60a3\u306b\u304a\u3051\u308b\u795e\u7d4c\u753b\u50cf\u306e\u9032\u6b69\u3068\u5c55\u671b. \u6700\u65b0\u7cbe\u795e\u533b\u5b66, 9, 409-411, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4: mismatch negativity. \u5206\u5b50\u7cbe\u795e\u533b\u5b66, 4, 58-59, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4: \u7cbe\u795e\u79d1\u5c02\u9580\u533b\u5236\u5ea6. \u6771\u4eac\u7cbe\u795e\u75c5\u9662\u5354\u4f1a\u8a8c, 22, 14-18, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4: \u5dfb\u982d\u8a00\uff1a\u7cbe\u795e\u533b\u5b66\u306e\u672a\u6765\u4e88\u60f3. \u7cbe\u795e\u533b\u5b66, 46, 1254-1255, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4: \u7d71\u5408\u5931\u8abf\u75c7\u306eMRI\u8a3a\u65ad. Clinical Neuroscience, 22, 617, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4, \u7af9\u5185\u76f4\u6a39: \u904e\u63db\u6c17\u75c7\u5019\u7fa4. \u5065\u5eb7\u6559\u5ba44\u6708\u53f7, 74-79, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4, \u6210\u7530\u535a\u4e4b: \u53cc\u6975\u6027\u969c\u5bb3\u306e\u795e\u7d4c\u753b\u50cf. \u7cbe\u795e\u79d1, 4(5):299-306, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4, \u6cb3\u897f\u5343\u79cb, \u90fd\u7532\u5d07, \u77f3\u5ddd\u771f\u543e, \u677e\u672c\u4fca\u5f66: \u533b\u5e2b\u306eON\/OFF\uff1a\u81e8\u5e8a\u5404\u9818\u57df\u306e2004-2005\u30c8\u30d4\u30c3\u30af\u30b9\u7cbe\u795e\u79d1, \u6cbb\u7642\u5225\u518a, 86, 32-33, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4, \u6cb3\u897f\u5343\u79cb, \u65e5\u91ce\u535a\u662d, \u677e\u6751\u96c4\u5f66, \u53e4\u5ddd\u826f\u5b50, \u90fd\u7532\u3000\u5d07, \u5185\u9580\u5927\u4e08, \u6210\u7530\u535a\u4e4b, \u5cb8\u7530\u90c1\u5b50, \u53e4\u91ce \u62d3, \u6749\u5c71\u76f4\u4e5f, \u5869\u5d0e\u660c\u4e00, \u5c0f\u7530\u539f\u4fca\u6210: \u7cbe\u795e\u795e\u7d4c\u75be\u60a3\u306e\u5305\u62ec\u7684\u75c5\u614b\u7814\u7a76-\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u533b\u5b66\u90e8\u7cbe\u795e\u533b\u5b66\u6559\u5ba4\u306e\u751f\u7269\u5b66\u7684\u7cbe\u795e\u533b\u5b66\u7814\u7a76\u306e\u73fe\u72b6-. \u8133\u3068\u7cbe\u795e\u306e\u533b\u5b66, 15, 31-37, 2004<\/p>\n
\u5c0f\u7530\u539f\u4fca\u6210\uff1a\u7cbe\u795e\u533b\u5b66\u3068\u6210\u5e74\u5f8c\u898b\u5236\u5ea6\u3000\u5b9f\u4f8b\u306b\u3064\u3044\u3066\u3000\u4fdd\u4f50\u4f8b\uff0e\u6700\u65b0\u7cbe\u795e\u533b\u5b66\uff0c9\uff0c35-39\uff0c2004.<\/p>\n
\u5c0f\u7530\u539f\u4fca\u6210, \u5c71\u7530\u5eb7\u5f18, \u85e4\u7530\u7d14\u4e00, \u6d66\u4e45\u4fdd\u5b89\u8f1d\u5b50, \u5c71\u7530\u670b\u6a39, \u5c0f\u962a\u61b2\u53f8, \u5e73\u5b89\u826f\u96c4: \u6a2a\u6d5c\u5e02\u5927\u30bb\u30f3\u30bf\u30fc\u75c5\u9662\u7cbe\u795e\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u6642\u9593\u5916\u6551\u6025\u5165\u9662\u306e\u5b9f\u614b. \u7cbe\u795e\u533b\u5b66, 46, 2004, 967-972<\/p>\n
\u6cb3\u897f\u5343\u79cb\uff0c\u5e73\u5b89\u826f\u96c4\uff1a\u65b0\u898f\u6297\u7cbe\u795e\u75c5\u85ac\u306e\u7b49\u4fa1\u63db\u7b97\uff0c\u533b\u4e8b\u65b0\u5831\uff0c4194\uff0c99-100\uff0c2004<\/p>\n
\u6cb3\u897f\u5343\u79cb\uff0c\u5cb8\u7530\u90c1\u5b50\uff0c\u53e4\u91ce\u62d3\uff1a\u60aa\u6027\u75c7\u5019\u7fa4\u3068\u907a\u4f1d\u5b50\u591a\u578b\uff0e\u5206\u5b50\u7cbe\u795e\u533b\u5b66\uff0c4\uff0c27-34\uff0c2004<\/p>\n
\u5c71\u7530\u670b\u6a39, \u5e73\u5b89\u826f\u96c4: \u7761\u7720\u85ac\u306e\u4f7f\u3044\u65b9\u3068\u52b9\u679c\u306e\u898b\u6975\u3081\u65b9. \u6cbb\u7642, 86;242-246, 2004<\/p>\n
\u5c71\u7530\u670b\u6a39, \u4e0a\u539f\u4e45\u7f8e, \u53e4\u91ce\u62d3, \u5c0f\u5cf6\u514b\u592b, \u90fd\u7532\u5d07, \u5e84\u53f8\u7f8e\u9999, \u5c0f\u7530\u539f\u4fca\u6210, \u5c0f\u962a\u61b2\u53f8, \u5e73\u5b89\u826f\u96c4: \u7d71\u5408\u5931\u8abf\u75c7\u6cbb\u7642\u306b\u304a\u3051\u308b\u591a\u65bd\u8a2d\u3067\u306e\u6297\u7cbe\u795e\u75c5\u85ac\u306e\u591a\u5264\u4f75\u7528\u30fb\u5927\u91cf\u7642\u6cd5\u304b\u3089olanzapine\u3078\u306e\u5207\u308a\u66ff\u3048\u7814\u7a76. \u81e8\u5e8a\u7cbe\u795e\u85ac\u7406, 7, 1769-1784 2004<\/p>\n
\u5c71\u7530\u5eb7\u5f18, \u5e73\u5b89\u826f\u96c4: \u7761\u7720\u969c\u5bb3. \u6cbb\u7642, 86;091-098, 2004<\/p>\n
\u677e\u6751\u96c4\u5f66, \u5e73\u5b89\u826f\u96c4: \u6162\u6027\u4e0d\u7720\uff08\u7cbe\u795e\u751f\u7406\u6027\u4e0d\u7720\uff09\u3078\u306e\u5bfe\u5fdc\u2015\u975e\u85ac\u7269\u7642\u6cd5\u3092\u4e2d\u5fc3\u306b\u2015. \u6cbb\u7642, 86;466-468, 2004<\/p>\n
\u677e\u672c\u4fca\u5f66, \u4e0a\u689d\u6566\u53f2, \u5c71\u53e3\u4e9c\u5e0c\u5b50, \u5ca1\u7530\u5e78\u4e4b, \u5409\u5ddd\u548c\u7537: \u899a\u305b\u3044\u5264\u4f9d\u5b58\u75c7\u6210\u4eba\u60a3\u8005\u306b\u304a\u3051\u308b\u6ce8\u610f\u6b20\u9665\/\u591a\u52d5\u6027\u969c\u5bb3\u306e\u65e2\u5f80?Wender Utah Rating Scale\u3092\u7528\u3044\u305f\u4e88\u5099\u7684\u7814\u7a76. \u7cbe\u795e\u533b\u5b66 46: 89-97, 2004<\/p>\n
\u677e\u672c\u4fca\u5f66: \u6442\u98df\u969c\u5bb3\u3068\u899a\u9192\u5264\u2500\u4e71\u7528\u7269\u8cea\u306e\u98df\u884c\u52d5\u3078\u306e\u5f71\u97ff\u2500. \u5fc3\u8eab\u533b\u5b66 44; 99-104, 2004<\/p>\n
\u677e\u672c\u4fca\u5f66, \u5ca1\u7530\u5e78\u4e4b, \u67d1\u672c\u7f8e\u548c, \u5409\u5ddd\u548c\u7537: \u6cd5\u7684\u63aa\u7f6e (\u901a\u5831\u7fa9\u52d9) \u3068\u7269\u8cea\u4f9d\u5b58\u30fb\u4e71\u7528\uff0d\u7279\u96c6 \u7269\u8cea\u4f9d\u5b58\u75c7\u306e\u73fe\u72b6\u3068\u6cbb\u7642\uff0d. \u7cbe\u795e\u79d1\u6cbb\u7642\u5b66 19: 1433-1439, 2004<\/p>\n
\u5c71\u53e3\u4e9c\u5e0c\u5b50, \u677e\u672c\u4fca\u5f66, \u8fd1\u85e4\u667a\u6d25\u6075, \u5c0f\u7530\u539f\u4fca\u6210, \u7af9\u5185\u76f4\u6a39, \u5c0f\u962a\u61b2\u53f8, \u6fa4\u7530\u5143\uff1a\u5927\u5b66\u751f\u306b\u304a\u3051\u308b\u81ea\u50b7\u884c\u70ba\u306e\u7d4c\u9a13\u7387\u3000\u81ea\u8a18\u5f0f\u8cea\u554f\u7968\u306b\u3088\u308b\u8abf\u67fb\uff0e\u7cbe\u795e\u533b\u5b66\uff0c46\uff0c473-479\uff0c2004<\/p>\n
\u5ca1\u7530\u5e78\u4e4b, \u677e\u672c\u4fca\u5f66, \u5b89\u85e4\u4e45\u7f8e\u5b50, \u5409\u5ddd\u548c\u7537\uff1a\u80fd\u529b\u8a55\u4fa1\u3068\u8a3a\u65ad\u66f8\u30fb\u9451\u5b9a\u66f8\uff0d\uff29\uff23\uff26\u306e\u5229\u7528\u306e\u5b9f\u969b\uff0d\uff0e\u81e8\u5e8a\u7cbe\u795e\u533b\u5b6633:1131-1139, 2004<\/p>\n
\u90fd\u7532\u5d07: Argyrophilic grain disease(\u55dc\u9280\u6027\u30b0\u30ec\u30a4\u30f3\u75f4\u5446)\u306e\u75c5\u7406\u5b66\u7684,\u751f\u5316\u5b66\u7684,\u907a\u4f1d\u5b66\u7684\u7814\u7a76\uff0e\u6a2a\u6d5c\u533b\u5b66\uff0c55;67-72\uff0c2004<\/p>\n
\u90fd\u7532\u5d07\uff0c\u5185\u9580\u5927\u4e08: Perospirone\u306b\u3088\u3063\u3066\u7cbe\u795e\u75c5\u5f8c\u6291\u3046\u3064\u304c\u6539\u5584\u3057\u305f\u7d71\u5408\u5931\u8abf\u75c7\u306e1\u4f8b\uff0e\u7cbe\u795e\u533b\u5b66\uff0c46;865-867\uff0c2004<\/p>\n
\u90fd\u7532\u5d07\uff0c\u5c0f\u962a\u61b2\u53f8: \u75f4\u5446\u306e\u85ac\u7269\u7642\u6cd5\uff0e\u7cbe\u795e\u533b\u5b66\uff0c46\uff0c124-132\uff0c2004<\/p>\n
\u90fd\u7532\u3000\u5d07: \u6297\u7cbe\u795e\u75c5\u85ac\u7dad\u6301\u7642\u6cd5\u4e2d\u306e\u526f\u4f5c\u7528\u8efd\u6e1b\u3092\u76ee\u7684\u3068\u3057\u305fperospirone\u3078\u306e\u5207\u308a\u66ff\u3048.\u3000\u81e8\u5e8a\u7cbe\u795e\u85ac\u74067;581-587, 2004.<\/p>\n
\u90fd\u7532\u3000\u5d07\u3001\u4e95\u95a2\u6804\u4e09: \u55dc\u9280\u6027\u30b0\u30ec\u30a4\u30f3\u578b\u75f4\u5446.\u3000\u65e5\u672c\u81e8\u5e8a62\u5897\u520a\u53f71\u300c\u75f4\u5446\u75c7\u5b66(2)\u300d:189-192, 2004.<\/p>\n
\u52a0\u85e4\u5927\u6148, \u6cb3\u897f\u5343\u79cb, \u5e73\u5b89\u826f\u96c4: \u6297\u3046\u3064\u85ac\u306e\u30c8\u30d4\u30c3\u30af\u30b9(1)SSRI\u306e\u6cbb\u7642\u5fdc\u7b54\u6027\u3068\u30bb\u30ed\u30c8\u30cb\u30f3\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fc. Conical Neuroscience, 22, 876-877, 2004<\/p>\n
\u5185\u9580\u5927\u4e08, \u571f\u8c37\u90a6\u79cb, \u51a8\u6c38\u3000\u683c, \u90fd\u7532\u3000\u5d07, \u5927\u5cf6\u5065\u4e00, \u79cb\u5c71\u6cbb\u5f66, \u6c60\u7530\u7814\u4e8c, \u7e54\u7530\u8fb0\u90ce, \u5e73\u5b89\u826f\u96c4: \u75f4\u5446\u3092\u4f34\u3046\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u306e\u81e8\u5e8a\u5897\u3092\u5448\u3057\u305f\u3068\u9280\u6027\u9846\u7c92\u75f4\u5446\uff08argyrophilic grain disease\uff09\u306e1\u5256\u691c\u4f8b. \u8133\u3068\u795e\u7d4c, 56, 785-788, 2004<\/p>\n
\u6210\u7530\u535a\u4e4b, \u5c0f\u7530\u539f\u4fca\u6210, \u677e\u672c\u4fca\u5f66, \u6728\u6751\u8302, \u5c71\u7530\u670b\u6a39, \u4e95\u95a2\u6804\u4e09, \u5bae\u5ddd\u548c\u54c9, \u65e5\u91ce\u535a\u662d, \u52a0\u85e4\u5927\u6148, \u5c0f\u962a\u61b2\u53f8, \u5e73\u5b89\u826f\u96c4: \u5e7b\u899a\u30fb\u5984\u60f3\u3092\u5448\u3057\u305f\u9ad8\u9f62\u767a\u75c7\u306eMELAS\u306e1\u4f8b. \u8133\u3068\u795e\u7d4c, 56, 345-349,2004<\/p>\n
\u85e4\u7530\u7d14\u4e00, \u91d1\u4e95\u6676\u5b50, \u7d30\u5cf6\u82f1\u6a39, \u4f50\u85e4\u73b2\u5b50, \u5742\u672c\u8aa0, \u5c0f\u7530\u539f\u4fca\u6210\uff1a\u6cbb\u7642\u7d4c\u904e\u4e2d\u306b\u75f4\u5446\u69d8\u75c7\u72b6\u3092\u5448\u3057\u305fACTH\u5358\u72ec\u6b20\u640d\u75c7\u306e1\u4f8b\uff0e\u795e\u5948\u5ddd\u770c\u7cbe\u795e\u533b\u5b66\u4f1a\u8a8c\uff0c53\uff0c45-50\uff0c2003. \uff082004\u5e74\u767a\u884c\uff09<\/p>\n
\u6d45\u898b\u3000\u525b, \u6210\u7530\u535a\u4e4b, \u5e73\u5b89\u826f\u96c4: \u7d71\u5408\u5931\u8abf\u75c7\u306b\u304a\u3051\u308b\u5927\u8133\u306e\u9032\u884c\u6027\u5f62\u614b\u5909\u5316. \u7cbe\u795e\u795e\u7d4c\u5b66\u96d1\u8a8c, 106, 987-996, 2004<\/p>\n
\u6d45\u898b\u525b, \u677e\u672c\u4fca\u5f66, \u963f\u702c\u5ddd\u5b5d\u6cbb, \u5c71\u53e3\u4e9c\u5e0c\u5b50, \u78ef\u5cf6\u5927\u8f14, \u6728\u6751\u8302, \u9577\u6cbb\u88d5\u5b50, \u53e4\u5ddd\u826f\u5b50, \u5c0f\u91ce\u702c\u96c5\u4e5f, \u4e95\u95a2\u6804\u4e09, \u5c0f\u962a\u61b2\u53f8\uff1a\u7fd2\u6163\u7684\u81ea\u50b7\u884c\u70ba\u3092\u5448\u3059\u308b\u60a3\u8005\u306e\u81e8\u5e8a\u7684\u7279\u5fb4\u3000\u89e3\u96e2\u306e\u8996\u70b9\u304b\u3089\u306e\u691c\u8a0e\u3000\u4e88\u5099\u7684\u8abf\u67fb\uff0e\u795e\u5948\u5ddd\u770c\u7cbe\u795e\u533b\u5b66\u4f1a\u8a8c\uff0c53\uff0c25-33\uff0c2003. \uff082004\u5e74\u767a\u884c\uff09<\/p>\n
<\/div>\n
\u8457\u66f8<\/div>\n
Arai T, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, Yagishita S, Oda T, Odawara T, Iseki E, Ikeda K: Tau pathology of sporadic tauopathies. Molecular Neurobiology of Alzheimer disease and related disorders. M Takeda, T Tanaka, R Cacabelos (eds),Basel, Karger,p52-61,2004<\/p>\n
Uchikado H, Iseki E, Tsuchiya K, Togo T, Katsuse O, Ueda K, Kato M, Kosaka K: Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology-Lewy pathology causes neuronal loss inducing progressive dementia. review series dementia, Issue 3, 19-21 Helix Communication, 2004<\/p>\n
\u5e73\u5b89\u826f\u96c4\uff1a\u6297\u3046\u3064\u85ac\u306e\u9078\u3073\u65b9\u3068\u4f7f\u3044\u65b9, \u30e1\u30f3\u30bf\u30eb\u30b1\u30a2 \u30c9\u30e9\u30c3\u30b0&\u6cbb\u7642\u30ac\u30a4\u30c92004-2005\uff0e\u4e0a\u5cf6\u56fd\u5229\uff08\u7de8\uff09\uff1a\u30e1\u30c7\u30a3\u30ab\u30eb\u30c9\u30a5\uff0c44-52\uff0c2003\uff082004\u5e74\u767a\u884c\uff09<\/p>\n
\u5e73\u5b89\u826f\u96c4\uff1a\u65b0\u898f\u6297\u7cbe\u795e\u75c5\u85ac\u306e\u526f\u4f5c\u7528, \u65b0\u898f\u6297\u7cbe\u795e\u75c5\u85ac\u306e\u3059\u3079\u3066\uff0e\u52a0\u85e4\u9032\u660c\uff0c\u4e0a\u5cf6\u56fd\u5229\uff0c\u5c0f\u5c71\u3000\u53f8\uff08\u7de8\uff09\uff1a\u5148\u7aef\u533b\u5b66\u793e\uff0c192-199\uff0c2004<\/p>\n
\u6cb3\u897f\u5343\u79cb\uff1a\u6297\u3046\u3064\u85ac\u306e\u4ee3\u8b1d\uff0e\u5c71\u7530\u548c\u592b\uff08\u7de8\uff09\uff1a\u6297\u3046\u3064\u85ac\u306e\u9078\u3073\u65b9\u3068\u4f7f\u3044\u65b9\uff0c\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c99-106\uff0c2004<\/p>\n
\u677e\u672c\u4fca\u5f66 (\u5171\u8457): \u30a2\u30eb\u30b3\u30fc\u30eb\u306a\u3069\u306e\u4f9d\u5b58\u75c7. \u306f\u305f\u3089\u304f\u4eba\u306e\u3053\u3053\u308d\u306e\u5065\u5eb7\uff0d\u81ea\u5206\u3089\u3057\u304f\u305f\u304f\u307e\u3057\u304f\uff0d(\u3053\u3053\u308d\u306e\u5065\u5eb7\u3092\u8003\u3048\u308b\u4f1a, \u306f\u305f\u3089\u304f\u4eba\u306e\u3053\u3053\u308d\u306e\u5065\u5eb7\u30b0\u30eb\u30fc\u30d7\u7de8). \u65b0\u8208\u533b\u5b66\u793e, \u6771\u4eac, 23-25, 2004<\/p>\n
\u5185\u9580\u5927\u4e08, \u4e95\u95a2\u6804\u4e09\uff1a\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u75f4\u5446\u3068\u8133\u8840\u7ba1\u6027\u75f4\u5446\uff0e\u5bae\u5ca1\u7b49(\u7de8)\uff1a \u7cbe\u795e\u79d1\u3000\u5fc5\u9808\u85ac\u3092\u63a2\u308b,\u3000\u4e2d\u5916\u533b\u5b66\u793e, \u6771\u4eac, 59-69, 2004<\/p>\n<\/div>\n
<\/p>\n
<\/div>\n
\n
\n
\n
<\/div>\n
$\"\u7814\u7a76\u7d39\u4ecb\"$ <\/a><\/p>\n
<\/div>\n
\u5f53\u6559\u5ba4\u306e\u5404\u7814\u7a76\u30c1\u30fc\u30e0\u3068\u7814\u7a76\u5185\u5bb9\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002
\n <\/p>\n<\/div>\n
\n
<\/div>\n
$\"\u5b66\u4f1a\u767a\u8868\u30fb\u7559\u5b66\"$ <\/a><\/p>\n
<\/div>\n
\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u6d3b\u52d5\u3001\u6d77\u5916\u7559\u5b66\u30fb\u7814\u4fee\u3082\u975e\u5e38\u306b\u6d3b\u767a\u3067\u3059\u3002
\n <\/p>\n<\/div>\n
\n
<\/div>\n
$\"\u696d\u7e3e\"$ <\/a><\/p>\n
<\/div>\n
\u5e73\u621025\u5e74\u4ee5\u964d\u306e\u8ad6\u6587\u30fb\u5b66\u4f1a\u767a\u8868\u7b49\u306e\u30ea\u30b9\u30c8\u3067\u3059\u3002
\n <\/p>\n<\/div>\n
\n
<\/div>\n
$\"\u6b74\u4ee3\u6a2a\u4e95\u8cde\u53d7\u8cde\u8005\"$ <\/a><\/p>\n
<\/div>\n
\u512a\u308c\u305f\u7814\u7a76\u696d\u7e3e\u3092\u53ce\u3081\u305f\u6559\u5ba4\u30b9\u30bf\u30c3\u30d5\u306b\u6bce\u5e74\u6388\u4e0e\u3055\u308c\u308b\u8cde\u3067\u3059\u3002
\n <\/p>\n<\/div>\n<\/div>\n
<\/p>\n<\/div>\n
<\/p>\n<\/div>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
\u30db\u30fc\u30e0\u3000\uff1e\u3000\u7814\u7a76\u7d39\u4ecb\u3000\uff1e\u3000\u696d\u7e3e\u3000\uff1e\u3000\u8457\u66f8\u30fb\u8ad6\u6587\uff082004\uff09 \u8457\u66f8\u30fb\u8ad6\u6587\uff082004\uff09 Thesis 2004 \u5e73\u621016\uff082004\uff09\u5e74\u767a\u8868\u306e\u8ad6\u6587\u3068\u8457\u66f8\u3067\u3059\u3002 \u4ee4\u548c\u5143\uff082019\uff09\u5e74\u3000| […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1848","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/pages\/1848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/comments?post=1848"}],"version-history":[{"count":8,"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/pages\/1848\/revisions"}],"predecessor-version":[{"id":2632,"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/pages\/1848\/revisions\/2632"}],"wp:attachment":[{"href":"http:\/\/www-user.yokohama-cu.ac.jp\/~psychiat\/wp-json\/wp\/v2\/media?parent=1848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}